Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Ride the Tiger with CD -- Ignore unavailable to you. Want to Upgrade?

To: ralfph who wrote (310644)	7/29/2025 1:33:40 PM
From: ogi	1 Recommendation Recommended By ralfph Read Replies (1) \| Respond to of 312766

The chart told you to wait! Better entry today for certain, which may still get better in the weeks ahead before assays. Or it may not!! I don't see a pump, I do see very well reasoned and supported arguments for why Rak's BiTe target could be huge. Typical jr action . The opportunity remains intact. In jrs the majority of time ,it is a bad idea to hold for assays, especially the very first holes on a project. After assays you have a lot more info to make an investment decision. That said if the assays for BiTe are one of the rare first pass discovery holes , you must pay more to play and I think in this instance I have said that Snowline's success has changed how the market will react to success for RAK. If they have a discovery, the reaction will be rapid, unlike SGD where the implications of discovery were overlooked in the immediate and opportunity remain quiet after assays were published.